New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older Business Wire Source link
Phase 3: Delgocitinib improves chronic hand eczema in adolescents Contemporary Pediatrics Source link
Shaperon secures phase 2 trials for atopic dermatitis treatment Nugel after positive review – CHOSUNBIZ 조선비즈 Source link
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis Dermatology Times Source link